Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2010 1
2013 1
2014 2
2015 5
2016 3
2017 1
2018 5
2019 3
2020 4
2021 7
2022 4
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review.
Askari E, Moghadam SZ, Wild D, Delpassand E, Baldari S, Nilica B, Hartrampf PE, Kong G, Grana CM, Alexander Walter M, Capoccetti F, Kasi PM, Strosberg J. Askari E, et al. Among authors: nilica b. J Nucl Med Technol. 2023 Mar;51(1):22-25. doi: 10.2967/jnmt.122.264904. Epub 2022 Oct 4. J Nucl Med Technol. 2023. PMID: 36195446 Free article. Review.
Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy.
Mair C, Warwitz B, Fink K, Scarpa L, Nilica B, Maffey-Steffan J, Buxbaum S, Virgolini IJ. Mair C, et al. Among authors: nilica b. Ann Nucl Med. 2018 Aug;32(7):499-502. doi: 10.1007/s12149-018-1264-x. Epub 2018 May 23. Ann Nucl Med. 2018. PMID: 29797003
Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up.
Maffey-Steffan J, Scarpa L, Svirydenka A, Nilica B, Mair C, Buxbaum S, Bektic J, von Guggenberg E, Uprimny C, Horninger W, Virgolini I. Maffey-Steffan J, et al. Among authors: nilica b. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):740. doi: 10.1007/s00259-019-04660-6. Eur J Nucl Med Mol Imaging. 2020. PMID: 31863137 Free PMC article.
Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours.
Virgolini I, Gabriel M, Kroiss A, von Guggenberg E, Prommegger R, Warwitz B, Nilica B, Roig LG, Rodrigues M, Uprimny C. Virgolini I, et al. Among authors: nilica b. Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):2072-83. doi: 10.1007/s00259-016-3395-4. Epub 2016 May 13. Eur J Nucl Med Mol Imaging. 2016. PMID: 27174220 Free PMC article. Review.
Enhancing Clinical Diagnosis for Patients With Persistent Pulmonary Abnormalities After COVID-19 Infection: The Potential Benefit of 68 Ga-FAPI PET/CT.
Sviridenko A, Boehm A, di Santo G, Uprimny C, Nilica B, Fritz J, Giesel FL, Haberkorn U, Sahanic S, Decristoforo C, Tancevski I, Widmann G, Loeffler-Ragg J, Virgolini I. Sviridenko A, et al. Among authors: nilica b. Clin Nucl Med. 2022 Dec 1;47(12):1026-1029. doi: 10.1097/RLU.0000000000004437. Epub 2022 Oct 15. Clin Nucl Med. 2022. PMID: 36257062 Free PMC article.
Nephrotoxicity and hematotoxicity one year after four cycles of peptide receptor radionuclide therapy (PRRT) and its impact on future treatment planning - A retrospective analysis.
Nilica B, Svirydenka A, Fritz J, Bayerschmidt S, Kroiss A, Gruber L, Virgolini IJ. Nilica B, et al. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 May-Jun;41(3):138-145. doi: 10.1016/j.remnie.2021.04.007. Epub 2021 Apr 15. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022. PMID: 35577489
31 results